Amarin | AMRN - Loan Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Amarin

Amarin reported $0 in Loan Capital for its fiscal quarter ending in June of 2022.


Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
AstraZeneca AZN:LN USD 27.65B 3.96B
Esperion Therapeutics ESPR:US USD 260.32M 417K
GlaxoSmithKline GSK:LN GBP 16.64B 391M
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Intercept Pharmaceuticals ICPT:US USD 223.35M 248K
Ionis Pharmaceuticals IONS:US USD 1.18B 1.66M
Novartis NOVN:VX USD 21.99B 203M